{"name":"Shandong New Time Pharmaceutical Co., LTD","slug":"shandong-new-time-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"shandongnewtime.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Esomeprazole sodium for injection","genericName":"Esomeprazole sodium for injection","slug":"esomeprazole-sodium-for-injection","indication":"Gastroesophageal reflux disease","status":"phase_2"},{"name":"Huazhi Rougan Granule Placebo granule","genericName":"Huazhi Rougan Granule Placebo granule","slug":"huazhi-rougan-granule-placebo-granule","indication":"Clinical trial control comparator (non-therapeutic use)","status":"marketed"},{"name":"Rulonilimab","genericName":"Rulonilimab","slug":"rulonilimab","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"AC591","genericName":"AC591","slug":"ac591","indication":"Relapsed or refractory follicular lymphoma","status":"phase_2"},{"name":"H02+CHOP","genericName":"H02+CHOP","slug":"h02-chop","indication":"Lymphoma (likely non-Hodgkin lymphoma or Hodgkin lymphoma based on CHOP standard use)","status":"phase_3"},{"name":"Rituxan +CHOP","genericName":"Rituxan +CHOP","slug":"rituxan-chop","indication":"Non-Hodgkin's lymphoma","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"F027","genericName":"F027","slug":"f027","indication":"Type 2 diabetes","status":"phase_3"},{"name":"F520","genericName":"F520","slug":"f520","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Huazhi Rougan granule","genericName":"Huazhi Rougan granule","slug":"huazhi-rougan-granule","indication":"Liver support and hepatic function (traditional indication)","status":"marketed"}]}],"pipeline":[{"name":"Esomeprazole sodium for injection","genericName":"Esomeprazole sodium for injection","slug":"esomeprazole-sodium-for-injection","phase":"phase_2","mechanism":"Inhibits the H+/K+ ATPase enzyme","indications":["Gastroesophageal reflux disease","Erosive esophagitis","Zollinger-Ellison syndrome"],"catalyst":""},{"name":"AC591","genericName":"AC591","slug":"ac591","phase":"phase_2","mechanism":"AC591 is a small molecule inhibitor of the PI3K delta subunit.","indications":["Relapsed or refractory follicular lymphoma"],"catalyst":""},{"name":"F027","genericName":"F027","slug":"f027","phase":"phase_3","mechanism":"F027 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"F520","genericName":"F520","slug":"f520","phase":"phase_2","mechanism":"F520 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"H02+CHOP","genericName":"H02+CHOP","slug":"h02-chop","phase":"phase_3","mechanism":"H02+CHOP is a chemotherapy combination regimen that uses doxorubicin, cyclophosphamide, vincristine, and prednisone to inhibit cancer cell proliferation and induce apoptosis.","indications":["Lymphoma (likely non-Hodgkin lymphoma or Hodgkin lymphoma based on CHOP standard use)"],"catalyst":""},{"name":"Huazhi Rougan Granule Placebo granule","genericName":"Huazhi Rougan Granule Placebo granule","slug":"huazhi-rougan-granule-placebo-granule","phase":"marketed","mechanism":"This is a placebo granule formulation with no active pharmaceutical ingredient and therefore no mechanistic action.","indications":["Clinical trial control comparator (non-therapeutic use)"],"catalyst":""},{"name":"Huazhi Rougan granule","genericName":"Huazhi Rougan granule","slug":"huazhi-rougan-granule","phase":"marketed","mechanism":"Huazhi Rougan granule is a traditional Chinese medicine formulation designed to support liver function and promote hepatic health through its herbal constituents.","indications":["Liver support and hepatic function (traditional indication)"],"catalyst":""},{"name":"Rituxan +CHOP","genericName":"Rituxan +CHOP","slug":"rituxan-chop","phase":"phase_3","mechanism":"Rituxan is a monoclonal antibody that targets and depletes CD20-positive B cells, while CHOP is a chemotherapy regimen that includes cyclophosphamide, doxorubicin, vincristine, and prednisone.","indications":["Non-Hodgkin's lymphoma","Chronic lymphocytic leukemia"],"catalyst":""},{"name":"Rulonilimab","genericName":"Rulonilimab","slug":"rulonilimab","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-04-23","type":"pipeline","source":"Medical Dialogues","summary":"Drug Alert: 70 Drug Samples Fail To Clear CDSCO Test, 1 Declared spurious - Medical Dialogues","headline":"Drug Alert: 70 Drug Samples Fail To Clear CDSCO Test, 1 Declared spurious","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOSGJkYVRwZURoZ21FbVN0WGpmeFBseHp0UW1ra3I5TDUzVXgwaWF4aHVSRkM3SjBJMVFrUGhhOE9EMHNnb0NJS1QyZGVfSzlKYkZwWXRtN1hrN0VpOTVia3ZLLU0yMzFzVnJLTWRxMkoyMXFaWndXbXBZXzVhbGJRZ3Rkd2FqWTk1VDI5VzdZRjdEUjB2TW10eGRSSnNtUjZ6RGYtcDRINjlDMEpHVExPZTVTV3RTeWRnSU5xd0RuckVhM2YtU2JjV3VmcC1vWFJqTlZmcERYbWhCYl9DUWo1dFRWMlc?oc=5","date":"2025-02-20","type":"pipeline","source":"The Straits Times","summary":"Singapore biotech tycoon Huang Zhenhua has assets frozen over $1.1 billion suit by pharma giant - The Straits Times","headline":"Singapore biotech tycoon Huang Zhenhua has assets frozen over $1.1 billion suit by pharma giant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQUS1FYmV5Qk1DOTJRU1U4dllxczdMZGRHVkZ1SnFDMENreE5lekppenVrV1JXTDB2d0xZRk8zckNTREtjUk5NQ1lZbllPdGVaM2NLYk9RUUFYZHFJSkJTWGN2Qi1LOVFvSnJqTnhJa3FhTXBpNXRGcGViMU5tLVJxX24tY0hnR2p5U3dFVTRHT05VWl91N0thellmWEdwcmE3RHd2WGV1VDhSS3l2QU5YdE9QMVh5OXE1WjFueVhhYmJqc0ZsN3c?oc=5","date":"2025-01-24","type":"pipeline","source":"The Straits Times","summary":"Changi Airport to focus on e-commerce, pharmaceutical shipments as cargo capacity tightens - The Straits Times","headline":"Changi Airport to focus on e-commerce, pharmaceutical shipments as cargo capacity tightens","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNbVpYY2lPZ2J5ZUQtMHlBdVBaNGxQM1ctNDNiWTBOX2hPaGVPUFNDdkl4WG5nekdVWmd2eTFQMlpvcE5SV2ZITzN6eF84d214MGdBc2NBWDJLUEkxdWVXcXI4WV8tblB6QmNWXy01SUFFQlg1UmcwMlM4bU4tVWFqaUZUdEVzN1dVcHpURE5nc2tlTmRmamRGcURDSGNBeElhN0lZNWJLVjZuZw?oc=5","date":"2019-11-15","type":"pipeline","source":"Cleanroom Technology","summary":"Thermo Fisher Scientific opens Customer Solution Center in Shanghai - Cleanroom Technology","headline":"Thermo Fisher Scientific opens Customer Solution Center in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxPLVJZb1BQVVFodnVSdzE3ZlpQemFBSlFsR0xPMnBSZjJCV2o2NVRuRDFGYVNSMVNVdHl4M051MGpuVmF3QW15bzJlbmtDQVMyelpxWTkwVzY2RFhVd1J2UFFYMVZQYTZaV2RQX0xTNFB4M0NuLTVDOFBKR2tLcklkajFORTc5Qk1WdXVNY1NKaXFBU1lMaTN0cDBOQXlNd1U4QUQ2ejNpTVZOSzNMSHJkRmNMYlMyUnRKa3FvYklJZndSRGZpWVlwSF9OZ3Z5V1QzZXZ6RFIxZWpLX1NNdVl1eXlER1YyTnc0SkVnd25oRTgzaUJvQkpUQkNTNDJWdVAzeDFNOUcxY3MxVURaRFE?oc=5","date":"2019-11-13","type":"pipeline","source":"PR Newswire","summary":"Thermo Fisher Scientific Opens Customer Solution Center in China to Support Pharmaceutical and Biopharmaceutical Laboratories - PR Newswire","headline":"Thermo Fisher Scientific Opens Customer Solution Center in China to Support Pharmaceutical and Biopharmaceutical Laborat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1SeVZfbk1PTUNOeVBiNVQzTGhHRUhick11VEhVdU1uMWs3MWpOYmR4TV9MM1pJUmctY1dsREJ3MzdRbkI1N2JFVGY0enRiNnd2REhqQXVuVGctVjFSYjJDNWln?oc=5","date":"2017-09-05","type":"pipeline","source":"Allied Market Research","summary":"Caffeine Market Size and Share | Industry Business Report, 2031 - Allied Market Research","headline":"Caffeine Market Size and Share | Industry Business Report, 2031","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"phase_2":4,"phase_3":3,"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}